Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan: NAYA Biosciences (NAYA)
Biotech success is based on the results of primary antibody tests and the influx of investment capital. NAYA Biosciences is striving to expand its NY-303 oncology pipeline to capture the liver cancer treatment niche. However, geopolitical tensions and sanctions are hindering global scientific exchange. The company's historical EV/EBITDA level demonstrates volatility, where represents the latest metric reading.
nayabiosciences.com - rincian analitis lan metrik utama (NAYA)
- rega saiki lan proyeksi nilai saham:
- indikator kapitalisasi bursa perusahaan:
- rincian valuasi buku bisnis:
- indikator beban kredit lan likuiditas emiten:
Utang marang Ekuitas NAYA Biosciences|NAYA - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal NAYA Biosciences Inc.|NAYA - Gunggung utang perusahaan|Utang marang nilai buku NAYA Biosciences Corp|NAYA - Utang jangka dawa|Utang jangka cendhak perusahaan NAYA Biosciences|Indikator likuiditas cepet nayabiosciences.com
- data bathi bisnis lan rasio investasi:
NAYA - Bathi pungkasan|Proyeksi bathi mangsa ngarep NAYA Biosciences|NAYA - Rasio rega marang bathi|Pangali Forward P/E NAYA Biosciences|NAYA - Kapitalisasi marang bathi resik kanthi nimbang wutah|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan NAYA Biosciences Corp|NAYA - Bathi sadurunge bunga, pajak, lan amortisasi|Bathi saben saham sajrone rolas wulan pungkasan NAYA Biosciences|NAYA - Bathi resik saben saham sajrone patang kuartal pungkasan|Wutah bathi EPS kuartalan nayabiosciences.com|NAYA - Wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi kanggo taun ngarep NAYA Biosciences
Analisis fundamental perusahaan:NAYA Bio (NAYA)
The development of NAYA Biosciences is focused on high-risk R&D projects and raising capital for antibody clinical trials. An analysis of the EV/EBITDA dynamics for this capital-intensive company at the current value of allows for a correlation between the total enterprise value and operating profitability before depreciation and interest. This multiple measures the payback period of assets including debt, determining the degree of undervaluation or the financial vulnerability of the issuer during the early stages of commercialization.
Analisis pesaing
Pangali EV/EBITDA ONC (BeiGene Corp)|HALO - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|RVMD: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|AAPG - Pangali EV/EBITDA|CG Oncology (CGON) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|UroGen Pharma Ltd - Nilai bisnis marang bathi operasional sadurunge panyusutan|BCAX (Bicara Bio) - Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Personalis Genomics PSNL|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Erasca, Inc. (ERAS)|delcath.com - Nilai perusahaan marang bathi operasional sadurunge panyusutan|Pangali EV/EBITDA YMAB (Y-mAbs Therapeutics, Inc.)|Pangali EV/EBITDA Aura Biosciences Inc AURA|CADL: Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Accuray, Inc.|SLS: Pangali EV/EBITDA|actuatetherapeutics.com (ACTU) - Pangali EV/EBITDA|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan CTOR|HURA: Nilai bisnis marang bathi operasional sadurunge panyusutan|Pangali EV/EBITDA TARA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan FATE (Fate Pharma)|Pangali EV/EBITDA WHWK (Aadi Bioscience)|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan TScan Therapeutics Inc (TCRX)|CSBR - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan XBiotech Inc.|cel-sci.com (CVM) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|OSTX - Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan|RADX (Radiopharm Theranostics) - Pangali EV/EBITDA|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Artiva (ARTV)|Pangali EV/EBITDA ANL|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan Veru Inc|Pangali EV/EBITDA TPST (Tempest Tx)|Xilio Therapeutics Inc (XLO) - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|RENB - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|MURA (Mural Oncology plc) - Nilai perusahaan marang bathi operasional sadurunge panyusutan|KAPA: Pangali EV/EBITDA|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan OnKure Therapeutics|GDTC (CytoMed Therapeutics Ltd) - Pangali EV/EBITDA|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Curis Corp CRIS|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Apollomics, Inc. (APLM)|Rasio total nilai perusahaan marang bathi operasional sadurunge panyusutan tharimmune.com|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Advanced Biomed ADVB|GNPX: Nilai perusahaan marang bathi operasional sadurunge panyusutan|Calidi Bio - Pangali EV/EBITDA|SBFM - Pangali EV/EBITDA|XBIO (xeneticbio.com) - Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan salariuspharma.com (SLRX)|PPBT (Purple Biotech Ltd.) - Pangali EV/EBITDA|Pangali EV/EBITDA AON|Pangali EV/EBITDA BGNE|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan Checkpoint Therapeutics Inc CKPT|Pangali EV/EBITDA ELEV (Elevation Oncology)|Pangali EV/EBITDA iCAD Inc. ICAD|IKNA - Nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan|NTBL (Notable Labs Ltd) - Nilai perusahaan marang bathi operasional sadurunge panyusutan|VIRX: Pangali EV/EBITDA|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan MorphoSys Corporation|AAPGV (Ascentage Pharma Group) - Pangali EV/EBITDA
